Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2014
10/02/2014WO2014157595A1 Novel polypeptides and utilization thereof
10/02/2014WO2014157107A1 Polypeptide having sialylated sugar chains attached thereto
10/02/2014WO2014155356A1 New uranium-chelating peptides derived from ef-hand calcium-binding motif useful for uranium biodetection and biodecontamination
10/02/2014WO2014155021A1 Bee calcium channel and uses
10/02/2014WO2014154905A1 A cancer vaccine for dogs
10/02/2014WO2014154904A1 A cancer vaccine for cats
10/02/2014WO2014154866A1 Methods and pharmaceuticals compositions for treating breast cancers
10/02/2014WO2014154848A1 Bone morphogenetic protein (bmp) variants with highly reduced antagonist sensitivity and enhanced specific biological activity
10/02/2014WO2014154844A1 Stabilized polyribonucleotide coding for an elastic fibrous protein
10/02/2014WO2014154655A1 Stabilised fmdv capsids
10/02/2014WO2014154647A1 Method and kit for detecting food allergens
10/02/2014WO2014154134A1 Polypeptide having inhibitory effect against infection by novel coronavirus hcov-emc 2012 and application of the polypeptide
10/02/2014WO2014154019A1 Long-lasting immune fusion protein for treating diabetes
10/02/2014WO2014153753A1 Gene mutant and use thereof
10/02/2014WO2014153674A1 Influenza virus-like particle production in plants
10/02/2014WO2014153625A1 Nanopore biosensors for detection of proteins and nucleic acids
10/02/2014WO2014153614A1 Improved methods for osteoarthritis therapy
10/02/2014US20140298545 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
10/02/2014US20140298542 Nucleic acid agents for overexpressing or downregulating rna interference targets and uses of same in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
10/02/2014US20140298538 Axmi205 variant proteins and methods of use
10/02/2014US20140296504 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/02/2014US20140296494 Protein expression in plants
10/02/2014US20140296487 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
10/02/2014US20140296486 Novel aav's and uses thereof
10/02/2014US20140296480 Peptide secreted by lactobacillus plantarum with immunomodulating function
10/02/2014US20140296479 D-aptide and retro-inverso aptide with maintained target affinity and improved stability
10/02/2014US20140296475 Method for preparing physiologically active polypeptide complex
10/02/2014US20140296434 Chromatography matrices including novel staphylococcus aureus protein a based ligands
10/02/2014US20140296325 Methods and compositions for inducing brown adipogenesis
10/02/2014US20140296161 Didemnin biosynthetic gene cluster in tistrella mobilis
10/02/2014US20140296160 Stabilized alpha helical peptides and uses thereof
10/02/2014US20140296154 Method of preventing development of psoriatic lesions
10/02/2014US20140296146 Thermostable Inhibitors of Activation of the Blood Clotting System Through Contact with Foreign Surfaces
10/02/2014US20140296145 Modified Human Growth Hormone Polypeptides and Their Uses
10/02/2014US20140296142 Gene therapy for diabetic neuropathy using an hgf isoform
10/02/2014US20140296132 Anti-bacterial Polypeptides and Pathogen Specific Synthetic Antibodies
10/02/2014US20140296131 Truncated GLP-1 Derivatives and Their Therapeutical Use
10/02/2014US20140296129 Regulation of receptor expression through delivery of artificial transcription factors
10/02/2014US20140296101 Secreted proteins and uses thereof
10/02/2014US20140296093 Use of multiple recombination sites with unique specificity in combinational cloning
10/02/2014US20140296091 Mycobacterium Antigens
10/02/2014US20140295551 Protein markers associated bone marrow stem cell differentiation into early progentior cells
10/02/2014US20140295544 Fluorescent proteins with increased activity in cells
10/02/2014US20140295528 Novelpolypeptides and bacteriophages specific to klebsiella pneumoniae capsular type strains
10/02/2014US20140295521 Method for reducing the immune response to a biologically active protein
10/02/2014US20140295520 Engineered subcellular compartments
10/02/2014US20140295496 Recombinant baculovirus and use thereof
10/02/2014US20140295491 Duckweed Hydrolysate and use Thereof
10/02/2014US20140295469 In Vitro Assessment of Cardiovascular Events by Assay for Neo-Eptitopes of Titin Protein
10/02/2014US20140295416 Novel Method of Cancer Diagnosis and Prognosis and Prediction of Response to Therapy
10/02/2014US20140295409 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/02/2014US20140295012 Latent human immunodeficiency virus reactivation
10/02/2014US20140294977 Radiation-Sterilized Biodegradable Drug Delivery Composition
10/02/2014US20140294942 Antiviral peptides effective against hepatitis c virus
10/02/2014US20140294941 Anti-angiogenic compositions and therapeutic applications thereof
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294930 STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
10/02/2014US20140294926 Treatment for exposure to nerve agent
10/02/2014US20140294919 Vaccines
10/02/2014US20140294918 Matricryptic ECM Peptides for Tissue Reconstruction
10/02/2014US20140294896 Cancer antigen
10/02/2014US20140294895 Expression of Protective Antigens in Transgenic Chloroplasts and the Production of Improved Vaccines
10/02/2014US20140294893 Recombinant nonpathogenic mdv vector providing multivalent immunity
10/02/2014US20140294892 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/02/2014US20140294888 Protective vaccine based on staphylococcus aureus sa2451 protein
10/02/2014US20140294886 Isolated protein and compositions comprising the protein
10/02/2014US20140294885 Heterologous expression of neisserial proteins
10/02/2014US20140294884 Meningococcus adhesins nada, app and orf 40
10/02/2014US20140294882 Compositions and methods for detecting, treating, and protecting against fusobacterium infection
10/02/2014US20140294880 Mutated lentiviral env proteins and their use as drugs
10/02/2014US20140294879 Modified rsv f proteins and methods of their use
10/02/2014US20140294878 Hypoallergenic variants of mal d 1, the major allergen from malus domestica
10/02/2014US20140294876 Amyloid Beta 1-6 Antigen Arrays
10/02/2014US20140294875 Leishmania Vaccine Using Sand Fly Salivary Immunogen
10/02/2014US20140294871 Amino acid sequences for controlling pathogens
10/02/2014US20140294866 Uses of Myostatin Antagonists
10/02/2014US20140294861 Isolated b7-h4 specific compositions and methods of use thereof
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294839 Methylated Peptides Derived from Tau Protein and Their Antibodies for Diagnosis and Therapy of Alzheimer's Disease
10/02/2014US20140294771 Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/02/2014US20140294762 Glycopegylation methods and proteins/peptides produced by the methods
10/02/2014US20140294759 Targeting regulatory t cells with heterodimeric proteins
10/02/2014US20140294758 Light chain immunoglobulin fusion proteins and methods of use thereof
10/01/2014EP2784160A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase
10/01/2014EP2784157A1 Design method for rna-binding protein using ppr motif, and use thereof
10/01/2014EP2784094A1 New uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination
10/01/2014EP2784087A1 Recombinant baculovirus and use thereof
10/01/2014EP2784086A1 Stem-cell engineering and the therapeutic use thereof
10/01/2014EP2784085A1 Human insulin analogue and acylated derivative thereof
10/01/2014EP2784084A1 IL-17 A/F heterologous polypeptides and therapeutics uses thereof
10/01/2014EP2784083A1 Bone Morphogenetic Protein (BMP) variants with highly reduced antagonist sensitivity and enhanced specific biological activity
10/01/2014EP2784082A1 Disease site-delivering pharmaceutical compositions comprising paclitaxel.
10/01/2014EP2783697A2 VIP Fragments and Methods of Use
10/01/2014EP2783694A2 Peptide sequences and compositions from Anopheles gambiase
10/01/2014EP2783003A1 Plants having enhanced yield-related traits and method for making the same
10/01/2014EP2782930A1 Methods of regulating angiogenesis and compositions capable of same
10/01/2014EP2782929A1 Method for production of factor viii
10/01/2014EP2782928A1 Mutations of histone proteins associated with proliferative disorders
10/01/2014EP2782927A1 Hla-dr7 hy epitope and method for treating leukemia
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 2916